One of the keys to this therapy from my understanding is in previous animal tests the therapy activated the immune system to recognise and attack the cancer once reintroduced back into the animal model.
It looks incredibly promising in combo with IMU's OnCARlytics IMO.
GLTAH & IMO
AFR - Why analysts love these eight medtech stocks, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $136.5M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.3¢ | $193.6K | 1.540M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13730 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 727520 | 7 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| ALA (ASX) Chart |